At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Scientists at Toronto Western Hospital and the University of Toronto have found a major mechanism that causes brain cells to die from stroke. They discovered that when brain cells are deprived of oxygen and vital nutrients, as happens to parts of the brain affected by a stroke, a special channel on the surface of those brain cells is activated, triggering a lethal chain reaction. The channel, called TRPM7, when activated causes brain cells to produce large quantities of free radicals – toxic molecules that break down the cell's DNA, proteins, and other components. Free radicals also cause TRPM7 to become even more active, causing massive overproduction of free radicals, resulting in death of the brain cell.
In a study published in the December 26 issue of Cell, an international science journal, the scientists also report that they have found a way to interfere with this lethal chain reaction. While brain cells can only survive for a few minutes without oxygen, interfering with the activity of TRPM7 allows brain cells to survive for more than three hours without oxygen and vital nutrients.
With this new understanding, there is now an opportunity to develop new medications that prevent activation of the TRPM7 channel. It will take approximately three years to develop a medication.
"This is a quantum leap forward in understanding how stroke causes brain damage," says Dr. Michael Tymianski, neurosurgeon at the Krembil Neuroscience Centre at Toronto Western Hospital and associate professor of surgery and physiology at the University of Toronto. "Now we can see the bigger picture of why brain cells die from stroke."
"This project is a primary example of how basic and clinical scientists can come together as an effective research team to tackle the major health problem of stroke," says Dr. John MacDonald, Chair of the Department of Physiology, Faculty of Medicine at the University of Toronto. "We are also very excited to explore the many potential functions of TRPM7 channels in the brain."
Until now, scientists thought they understood why brain cells die when deprived of oxygen and essential nutrients.
Past research suggested that the major culprit was glutamate, an amino acid normally used by brain cells to communicate by carrying signals from one brain cell to the next. Dying brain cells release glutamate, which attaches to a special channel called the NMDA receptor located on the surface of the neighbouring brain cells. This causes the NMDA channel to open and allows an influx of calcium ions into the brain cell. For years, it was thought that this sequence of events caused brain cells to die from stroke.
For this reason, many experimental medications for treating strokes were aimed at blocking the effects of glutamate on NMDA receptors. Although it worked in the lab, the medications failed to reduce brain damage in humans.
Despite three decades of research that pointed to glutamate as the culprit in cell death, the failure of these medications remained a mystery. To solve this mystery, Drs. Tymianski and MacDonald went back to the drawing board and discovered that glutamate was only one part of the reason why brain cells die from stroke.
"We have significant experience in translating such basic discoveries into drugs that might help patients. With thisnew knowledge, we will now focus on developing medications that we can inject into stroke patients up to several hours after a stroke. These medications will prevent the consequences of activating TRPM7, extend the life of brain cells after a stroke, and help improve the outcome of patients suffering from a stroke."
As the fourth most common cause of death in Canada, and the second leading cause of death in the world, stroke kills about 16,000 Canadians every year. Stroke is a major cause of disability, as people who survive strokes suffer irreparable damage to their brain cells. These effects can include partial paralysis, problems with thinking, problems with language, and difficulty with movement. Approximately 300,000 Canadians live with the effects of stroke.
The warning signs of a stroke include sudden weakness, trouble speaking, vision problems, headache, and dizziness.
This research was funded by grants from the Canadian Institutes of Health Research, the Ontario Heart and StrokeFoundation, and the National Institutes of Health of the United States of America.
Toronto Western Hospital has been serving the health care needs of its culturally diverse community for more than 100 years. Today, the hospital provides highly specialized tertiary care to people from surrounding areas and across Canada. Home to the Krembil Neuroscience Centre, one of the largest combined clinical and research neurological facilities in North America, the hospital also offers a community and population health program and expertise inmusculoskeletal health and arthritis. Toronto Western Hospital is one of three hospitals – including Toronto General Hospital and Princess Margaret Hospital – that make up University Health Network, a teaching hospital of the University of Toronto.
The University of Toronto (U of T), Canada's leading research university with over 60,000 students, was founded in1827 by British royal charter. For the tenth consecutive year, U of T has taken the top spot among medical/doctoral universities in the annual Maclean's magazine university ranking. The university now comprises 31 divisions, colleges and faculties on three campuses, including 14 professional faculties, numerous research centres and Canada's largest library system – one of the top research libraries in North America. U of T's Department ofPhysiology is the largest and most research-intensive university physiology department in Canada and has researchand training partnerships with numerous hospital-based research institutes.
For more information on CT Scan and MRI image, see this document below.
Media Contact: 416 340 4636